课题基金 / 基金详情

Integration and epigenetic regulation of the HHV-6 genome

Integration and epigenetic regulation of the HHV-6 genome
HHV-6 基因组的整合和​​表观遗传调控
批准号:
9267933
负责人:
Seth E Frietze
金额:
$17.24万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-05-01 至 2019-04-30

项目摘要

项目成果

Seth E Frietze的其他基金

相似基金

相关文献

中文摘要
翻译
 描述(申请人提供):在初次感染期间,疱疹病毒建立一种潜伏感染,使病毒在宿主中持续一生。最近发现,某些疱疹病毒在潜伏期将其基因组整合到宿主染色体的端粒中,而其他大多数疱疹病毒则将其基因组保持为细胞核中的Episome。其中一种病毒是人类疱疹病毒6型(HHV-6),它与一系列疾病有关,包括癫痫发作、脑炎和移植患者的移植排斥反应。然而,关于疱疹病毒感染的分子机制,包括控制病毒基因表达和DNA整合的机制以及病毒重新激活所需的事件,我们的知识存在严重差距。为了解决我们知识中的这些关键差距,我们建议使用我们的体外感染系统来整合、潜伏和重新激活HHV-6,并结合功能基因组学来确定病毒基因组在这些过程中的命运。我们将首先通过测量从裂解感染到潜伏感染的差异基因表达、染色质修饰和整合事件来确定病毒在潜伏和整合建立过程中的基因组特征(特定目标1)。接下来,我们将研究与病毒重新激活有关的病毒和细胞决定因素。在接受治疗时 在体外用组蛋白去乙酰酶抑制剂药物(HDACi)潜伏感染的细胞中,只有一小部分细胞重新激活。因此,我们假设病毒重新激活的细胞对药物治疗具有特有的基因表达反应,这将揭示参与维持潜伏期或病毒重新激活的细胞和病毒基因。我们将通过用HDACi处理细胞,用流式细胞仪分离重新激活和非重新激活的细胞,并执行目标1中描述的分析来确定重新激活的特征(特定的目标2)来定义这种药物反应。最后,我们将确定细胞的病毒基因组特征 ICHHV-6患者,以深入了解这些人的病毒调节,并验证我们的体外模型(特定目标3)。我们建议的实验将以高分辨率描述转录、染色质调节和病毒DNA整合在初始感染、潜伏期建立和重新激活过程中的关系。我们的特定目标的成功完成将提供所需的知识,以了解整合的潜伏病毒基因组的转录是如何受到控制的,从而为治疗移植期间的病毒并发症提供可能的治疗靶点。
英文摘要
 DESCRIPTION (provided by applicant): During primary infection, herpesviruses establish a latent infection that allows the virus to persist in the host for life. It was recently discovered hat certain herpesviruses integrate their genome into the telomeres of host chromosomes during latency, while most others maintain their genome as an episome in the nucleus. One of these viruses is human herpesvirus 6 (HHV-6), which is associated with a spectrum of diseases including seizures, encephalitis, and graft rejection in transplant patients. However, there are critical gaps in our knowledge regarding the molecular mechanisms of herpesvirus infections, including the mechanisms by which virus gene expression and DNA integration is controlled as well as the events required for virus reactivation. To address these critical gaps in our knowledge, we propose to use our in vitro infection system for HHV-6 integration, latency and reactivation coupled with functional genomics to determine the fate of the virus genome in these processes. We will first determine the viral genomic signatures during the establishment of latency and integration by measuring differential gene expression, chromatin modification and integration events during the transition from lytic to latent infection (Specific Aim 1). Next, we ill then investigate the viral and cellular determinants involved in virus reactivation. Upon treatment of latently infected cells with histone deacetylase inhibitor drugs (HDACi) in vitro, only in a fraction of the cells reactivate. We therefore hypothesize that virus-reactivating cells have a characteristic gene expression response to drug treatment, which will reveal cellular and viral genes that participate in either maintenance of latency or virus reactivation. We will define this drug response by treating cells with HDACi, isolation of reactivating and non-reactivating cells by FACS and performing the assays described in Aim 1 to determine the signature of reactivation (Specific Aim 2). Finally, we will determine the viral genomic signature of cells from iciHHV-6 patients to obtain an insight into the viral regulation in these individuals and to validae our in vitro model (Specific Aim 3). Our proposed experiments will describe, with high-resolution, the connections between transcription, chromatin regulation and viral DNA integration over the course of initial infection, establishment of latency and reactivation. Successful completion of our specific aims will provide knowledge required to understand how transcription from the integrated latent virus genome is controlled, thereby providing possible therapeutic targets to treat viral complications during transplantation.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Chromatin Profiles of Chromosomally Integrated Human Herpesvirus-6A.
染色体整合的人类疱疹病毒 6A 的染色质图谱。
DOI: 10.3389/fmicb.2019.01408
发表时间: 2019
期刊: Frontiers in microbiology
影响因子: 5.2
作者: [Saviola,AnthonyJ, Zimmermann,Cosima, Mariani,MichaelP, Signorelli,SylviaA, Gerrard,DianaL, Boyd,JosephR, Wight,DarrenJ, Morissette,Guillaume, Gravel,Annie, Dubuc,Isabelle, Flamand,Louis, Kaufer,BenediktB, Frietze,Seth]
通讯作者: Frietze,Seth
Project 2: Bromodomains as Epigenetic Modulators of Endocrine Responsiveness in ER+ Breast Cancer
Project 2: Bromodomains as Epigenetic Modulators of Endocrine Responsiveness in ER+ Breast Cancer
Deciphering the molecular mechanisms of histone code recognition by ATAD2/B
Understanding Ikaros molecular functions for targeted therapies of pre-B ALL
海外基金